Daratumumab associated hypogammaglobinemia and increased infection rates in multiple myeloma patients
Latest Information Update: 22 Jul 2020
At a glance
- Drugs Daratumumab (Primary) ; Immunoglobulins; Immunomodulators; Proteasome inhibitors
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 22 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association